Oncolytics Biotech Inc. (ONCY) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 7.49M | 6.84M | 14.05M | 18.9M | 18.49M | 18.88M | 22.91M | 30.63M | 33.38M | 38.17M | 45.34M | 31M |
| Cash & Short-Term Investments | 5.49M | 5.2M | 12.35M | 14.63M | 15.3M | 15.94M | 19.6M | 24.85M | 29.6M | 34.91M | 39.98M | 24.35M |
| Cash Only | 5.49M | 5.2M | 12.35M | 14.63M | 15.3M | 15.94M | 19.6M | 24.85M | 29.6M | 34.91M | 39.98M | 17.52M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.83M |
| Accounts Receivable | 961K | 573K | 54K | 72K | 89K | 68K | 104K | 1.57M | 102K | 15K | 630K | 559K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 1.02M | 1.22M | 980K | 1.09M | 848K | 623K | 0 | 0 | 0 |
| Total Non-Current Assets | 674K | 738K | 1.01M | 1.08M | 1.22M | 1.31M | 1.35M | 1.44M | 1.37M | 647K | 752K | 971K |
| Property, Plant & Equipment | 674K | 738K | 1.01M | 1.08M | 1.22M | 1.31M | 1.35M | 1.44M | 1.37M | 647K | 752K | 744K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 227K |
| Total Assets | 8.16M | 7.58M | 15.06M | 19.97M | 19.7M | 20.19M | 24.26M | 32.07M | 34.75M | 38.82M | 46.09M | 31.97M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -58.58% | -62.44% | -37.94% | -37.72% | -43.3% | -48% | -47.36% | 0.32% | -1.64% | 3.98% | 18.3% | -20.56% |
| Total Current Liabilities | 5.42M | 6.1M | 7.66M | 6.56M | 5.77M | 6.69M | 7.66M | 6.14M | 4.1M | 4.24M | 10.02M | 2.65M |
| Accounts Payable | 0 | 3.5M | 4.2M | 1.33M | 779K | 1.09M | 3.43M | 886K | 744K | 1.08M | 2.19M | 629K |
| Days Payables Outstanding | - | - | - | - | - | - | - | 1.04K | 675.47 | 1.41K | 1.69K | 736.5 |
| Short-Term Debt | 166K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 5.26M | 2.4M | 199K | 982K | 530K | 1.62M | 489K | 1.26M | 314K | 532K | 5.29M | 153K |
| Current Ratio | 1.38x | 1.12x | 1.84x | 2.88x | 3.21x | 2.82x | 2.99x | 4.99x | 8.14x | 9.01x | 4.53x | 11.69x |
| Quick Ratio | 1.38x | 1.12x | 1.84x | 2.88x | 3.21x | 2.82x | 2.99x | 4.99x | 8.14x | 9.01x | 4.53x | 11.69x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 7.87M | 5.28M | 7.29M | 7.33M | 7.44M | 7.52M | 7.54M | 7.62M | 7.68M | 7.02M | 7.05M | 7.08M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 342K | 370K | 557K | 597K | 710K | 787K | 813K | 891K | 948K | 290K | 323K | 346K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 2.62M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 13.29M | 11.38M | 14.94M | 13.88M | 13.21M | 14.2M | 15.21M | 13.76M | 11.78M | 11.26M | 17.07M | 9.73M |
| Total Debt | 508K | 563K | 835K | 888K | 1M | 1.06M | 1.06M | 1.12M | 1.13M | 423K | 514K | 479K |
| Net Debt | -4.99M | -4.64M | -11.52M | -13.74M | -14.3M | -14.88M | -18.53M | -23.73M | -28.48M | -34.49M | -39.47M | -17.04M |
| Debt / Equity | - | - | 7.26x | 0.15x | 0.15x | 0.18x | 0.12x | 0.06x | 0.05x | 0.02x | 0.02x | 0.02x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | -5.13M | -3.8M | 115K | 6.09M | 6.49M | 5.98M | 9.06M | 18.31M | 22.97M | 27.56M | 29.02M | 22.24M |
| Equity Growth % | -179% | -163.5% | -98.73% | -66.75% | -71.73% | -78.29% | -68.79% | -17.66% | -10.8% | 4% | 2.19% | -27.73% |
| Book Value per Share | -0.05 | -0.04 | 0.00 | 0.07 | 0.08 | 0.08 | 0.12 | 0.24 | 0.31 | 0.37 | 0.42 | 0.34 |
| Total Shareholders' Equity | -5.13M | -3.8M | 115K | 6.09M | 6.49M | 5.98M | 9.06M | 18.31M | 22.97M | 27.56M | 29.02M | 22.24M |
| Common Stock | 0 | 0 | 458.63M | 451.14M | 445.53M | 438.19M | 434.46M | 434.55M | 432.51M | 430.91M | 428.83M | 413.42M |
| Retained Earnings | -438.74M | -429.5M | -504.96M | -490.56M | -484.4M | -477.71M | -469.7M | -460.15M | -452.9M | -446M | -442.05M | -432.13M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 6.22M | 6.22M | 789K | 720K | 958K | 961K | 653K | 722K | 670K | 544K | 655K | 554K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |